Antiphospholipid Syndrome in Pediatrics

Rheumatic Disease Clinics of North America

Volumn 33, Issue 3, 2007, Pages 499-523

  Ravelli, Angelo ^a,b   Martini, Alberto ^a,b  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; DAPSONE; DEFIBROTIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROSTACYCLIN; RITUXIMAB; STREPTOKINASE; UROKINASE; WARFARIN;

ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; CASE REPORT; CHILDHOOD DISEASE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG MEGADOSE; FETUS WASTAGE; HEMOLYTIC ANEMIA; HUMAN; HYPOPROTHROMBINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY DIAGNOSIS; LOW DRUG DOSE; MALE; OUTCOMES RESEARCH; PATHOGENESIS; PHYSICAL EXAMINATION; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VEIN THROMBOSIS;

EID: 34948851888     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.07.001     Document Type: Review

References (74)

1. Harris N.E., and Khamashta M.A. Antiphospholipid syndrome. In: Hochberg M.C., Silman A.J., Smolen J.S., et al. (Eds). Rheumatology. 3rd edition (2003), Elsevier, Philadelphia 1445-1453
2. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N Engl J Med 346 10 (2002) 752-763
3. Olive D., André E., Brocard O., et al. Lupus érythémateux disséminé revélé par des thrombophlébites des membres inferieurs. Arch Fr Pediatr 36 9 (1979) 959-960
4. St Clair W., Jones B., Rogers J.S., et al. Deep venous thrombosis and a circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 135 3 (1981) 230-232
5. Ravelli A., and Martini A. Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin North Am 23 3 (1997) 657-676
6. Ravelli A., and Martini A. Antiphospholipid antibody syndrome. Pediatr Clin North Am 52 (2005) 469-491
7. von Scheven E., Athreya B.H., Rose C.D., et al. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 129 3 (1996) 339-345
8. Cimaz R., and Descloux E. Pediatric antiphospholipid syndrome. Rheum Dis Clin North Am 32 (2006) 553-573
9. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 42 7 (1999) 1309-1311
10. Bertolaccini M.L., and Hughes G.R.V. Antiphospholipid antibody testing: which are most useful for diagnosis?. Rheum Dis Clin North Am 32 (2006) 455-463
11. Hanly J.G. Antiphospholipid syndrome: an overview. CMAJ 168 13 (2003) 1675-1682
12. Harris E.N., Gharavi A.E., Patel S., et al. Evaluation of the anti-cardiolipin antibody test. Report of an International Workshop held 4 April 1986. Clin Exp Immunol 68 (1987) 215-222
13. Brandt J.T., Triplett D.A., Alving B., et al. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74 4 (1995) 1185-1190
14. Matsuura E., Igarashi Y., Yasuda T., et al. Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 179 2 (1994) 457-462
15. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
16. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 4 (2002) 1019-1027
17. Espinosa G., Cervera R., Font J., et al. Antiphospholipid syndrome: pathogenic mechanisms. Autoimmun Rev 2 2 (2003) 86-93
18. Mackworth-Young C.G. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 136 3 (2004) 393-401
19. Pierangeli S.S., Chen P.P., and Gonzales C. Antiphospholipid antibodies and the antiphospholipid syndrome : an update on treatment and pathogenetic mechanisms. Curr Opin Hematol 13 (2006) 366-375
20. Arnout J. The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia. Thromb Haemost 75 4 (1996) 536-541
21. Gharavi A.E., Wilson W., and Pierangeli S. The molecular basis of antiphospholipid syndrome. Lupus 12 8 (2003) 579-583
22. Giron-Gonzalez J.A., Garcia Del Rio E., Rodriguez C., et al. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31 8 (2004) 1560-1567
23. Hudson M., Herr A.-L., Rauch J., et al. The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol 30 11 (2003) 2385-2391
24. Angelini L., Ravelli A., Caporali R., et al. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 94 4 Pt 1 (1994) 500-503
25. Uziel Y., Laxer R.M., Blaser S., et al. Cerebral vein thrombosis in childhood systemic lupus erythematosus. J Pediatr 126 5 Pt 1 (1995) 722-727
26. Asherson R.A., Cervera R., Piette J.C., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 3 (1998) 195-207
27. Erkan D., Cervera R., and Asherson R.A. Catastrophic antiphospholipid syndrome. Where do we stand?. Arthritis Rheum 48 12 (2003) 3320-3327
28. Falcini F., Taccetti G., Ermini M., et al. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 24 2 (1997) 389-392
29. Orsino A., Schneider R., DeVeber G., et al. Childhood acute myelomonocytic leukaemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome. J Pediatr Hematol Oncol 26 5 (2004) 327-330
30. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 14 5 (2002) 548-552
31. Bernini J.C., Buchanan G.R., and Ashcraft J. Hypoprothombinemia and severe hemorrhage associated with a lupus anticoagulant. J Pediatr 123 6 (1993) 937-939
32. Eberhard A., Sparling C., Sudbury S., et al. Hypoprothombinemia in childhood systemic lupus erythematosus. Semin Arthritis Rheum 24 1 (1994) 12-18
33. Hudson N., Duffy C.M., Rauch J., et al. Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency. Lupus 6 1 (1997) 68-71
34. Josephson C., Nuss R., Jacobson L., et al. The varicella-autoantibody syndrome. Pediatr Res 50 3 (2001) 345-352
35. Kurugol Z., Vardar F., Ozkinay F., et al. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatr 89 10 (2000) 1186-1189
36. Avcin T., Cimaz R., and Meroni P.L. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 11 1 (2002) 4-10
37. Motta M., Tincani A., Lojacono A., et al. Neonatal outcome in patients with rheumatic disease. Lupus 13 9 (2004) 718-723
38. Boffa M.C., Aurousseau M.H., Lachassinne E., Dauphin H., Fain O., Le Toumelin P., et al. European register of babies born to mothers with antiphospholipid syndrome. Lupus 13 (2004) 713-717
39. Shergy W.J., Kredich D.W., and Pisetsky D.S. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus. J Rheumatol 15 9 (1988) 1389-1394
40. Montes de Oca M.A., Babron M.C., Bletry O., et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 66 6 (1991) 713-717
41. Molta C., Meyer O., Dosquet C., et al. Childhood-onset systemic lupus erythematosus: antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics 92 6 (1993) 849-853
42. Ravelli A., Caporali R., Di Fuccia G., et al. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 148 4 (1994) 398-402
43. Gattorno M., Buoncompagni A., Molinari A.C., et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 34 9 (1995) 873-881
44. Seaman D.E., Londino A.V., Kwoh C.K., et al. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 96 6 (1995) 1040-1045
45. Berube C., Mitchell L., Silverman E., et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 44 3 (1998) 351-356
46. Gedalia A., Molina J.F., Garcia C.O., et al. Anticardiolipin antibodies in chidlhood rheumatic disorders. Lupus 7 8 (1998) 551-553
47. von Scheven E., Glidden D.V., and Elder M.E. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome. Arthritis Rheum 47 4 (2002) 414-420
48. Campos L.M., Kiss M.H., D'Amico E.A., et al. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 12 11 (2003) 820-826
49. Levy D.M., Massicotte M.P., Harvey E., et al. Thromboembolism in paediatric lupus patients. Lupus 12 10 (2003) 741-746
50. Schmugge M., Revel-Vilk S., Hiraki L., et al. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus. J Pediatr 143 5 (2003) 666-669
51. Daugas E., Nochy D., Huong du L.T., et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13 1 (2002) 42-52
52. Caporali R., Ravelli A., Ramenghi B., et al. Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch Dis Child 67 11 (1992) 1384-1385
53. Andrews A., and Hickling P. Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis. Lupus 6 6 (1997) 556-557
54. Von Landenberg P., Lehmann H.W., Knoll A., et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 48 7 (2003) 1939-1947
55. Ravelli A., Martini A., and Burgio G.R. Antiphospholipid antibodies in paediatrics. Eur J Pediatr 153 7 (1994) 472-479
56. Gomez J.A., Martin H., Amigo M.C., et al. Long-term follow-up in 90 patients with primary antiphospholipid syndrome (PAPS). Do they develop lupus?. [abstract]. Arthritis Rheum 44 Suppl (2001) S146
57. Gattorno M., Falcini F., Ravelli A., et al. Outcome of primary antiphospholipid syndrome in childhood. Lupus 12 6 (2003) 449-453
58. Hochberg M.C. Updating the American College of Rheumatology criteria for the classification of systemic lupus erythematosus. [letter]. Arthritis Rheum 40 9 (1997) 1725
59. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 11 (1982) 1271-1277
60. Harris E.N., and Spinnato J.A. Should anticardiolipin tests be performed in otherwise healthy pregnant women?. Am J Obstet Gynecol 165 5 Pt 1 (1991) 1272-1277
61. Alarcon-Segovia D., Boffa M.C., Branch W., et al. Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 12 7 (2003) 499-503
62. Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5 Suppl 1 (1996) S16-S22
63. Khamashta M.A., Cuadrado M.J., Mujic F., et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332 15 (1995) 993-997
64. Crowther M.A., Ginsberg J.S., Julian J., et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349 12 (2003) 1133-1138
65. Finazzi G., Marchioli R., and Barbui T. A randomized clinical trial of oral anticoagulant therapy in patients with antiphospholipid antibody syndrome: the WAPS study. [abstract]. J Thromb Haemost 1 Suppl 1 (2003) OC365
66. Crowther M.A. Antiphospholipid antibody syndrome: further evidence to guide clinical practice?. J Rheumatol 31 8 (2004) 1474-1475
67. Levine S.R., Brey R.L., Tilley B.C., et al., APASS Investigators. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 291 5 (2004) 576-584
68. Wahl D., Regnault V., de Moerloose P., et al. Antiphospholipid antibodies and risk for recurrent vascular events. [letter]. JAMA 291 22 (2004) 2701-2702
69. Cabral A.R. Antiphospholipid antibodies and risk for recurrent vascular events. [letter]. JAMA 291 22 (2004) 2701
70. Ruiz-Irastorza G., Khamashta M.A., and Hughes G.R. Antiphospholipid antibodies and risk for recurrent vascular events. [letter]. JAMA 291 22 (2004) 2701
71. Erkan D., and Lockshin M.D. New treatments for antiphospholipid syndrome. Rheum Dis Clin North Am 32 (2006) 129-148
72. Silverman E. What's new in the treatment of pediatric SLE?. J Rheumatol 23 9 (1996) 1657-1660
73. Asherson R.A., Cervera R., de Groot P.G., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 7 (2003) 530-534
74. Hunt B.J., and Khamashta M.A. Management of the Hughes syndrome. Clin Exp Rheumatol 14 2 (1996) 115-117